Effect of vachadi kwatha & lekhana basti in Medoroga(Dyslipidemia)
Phase 2
- Conditions
- Health Condition 1: E669- Obesity, unspecified
- Registration Number
- CTRI/2024/05/067312
- Lead Sponsor
- Dr. Anjali Kanojia
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
Classical sign and symptoms of Medoroga
BMI 25 34 Kg/m2
Dearranged lipid profile
As per National Cholesterol Education Program Guidelines
Exclusion Criteria
Age group less than 20 & more than 60 yrs
Patient not fulfilling sign and symptoms of Medoroga as per classical text
Subjective and Objective criteria not fulfilling
BMI more than 35 Kg/m2
Very high ranges of lipid profile as per ATP III Classification (NCEP)
Pregnant or lactating women
Hypothyroidism, Endocrinopathies, DM-2 with complications
Patient suffering from any severe systemic diseases
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Improvement assess in terms of BMI and lipid profile on first second and third follow upTimepoint: Status of patient assess at zero day and after first follow up after second follow up and after complete treatment that is third follow up ( Day 0,15,30,45)
- Secondary Outcome Measures
Name Time Method Improvement in Sign & Symptoms of Medoroga (Dyslipidemia) patient in three follow up under 45 daysTimepoint: Evalutaion before treatment Day zero & after third follow up day 45